Efficacy and Safety of Vildagliptin in Combination With Pioglitazone in Patients With Type 2 Diabetes
Clinical trial NCT00099853 · COMPLETED
Trial details
- NCT number
- NCT00099853
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2004-05-01
- Primary completion
- 2008-01-01
- Enrollment
- 362
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.